title: Siamycins I and II, new anti-HIV-1 peptides: II. Sequence analysis and structure determination of siamycin I.
authors.affiliation: Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, CT 06492, USA.
authors.forename: D J
authors.initials: DJ
authors.lastname: Detlefsen
authors.forename: S E
authors.initials: SE
authors.lastname: Hill
authors.forename: K J
authors.initials: KJ
authors.lastname: Volk
authors.forename: S E
authors.initials: SE
authors.lastname: Klohr
authors.forename: M
authors.initials: M
authors.lastname: Tsunakawa
authors.forename: T
authors.initials: T
authors.lastname: Furumai
authors.forename: P F
authors.initials: PF
authors.lastname: Lin
authors.forename: M
authors.initials: M
authors.lastname: Nishio
authors.forename: K
authors.initials: K
authors.lastname: Kawano
authors.forename: T
authors.initials: T
authors.lastname: Oki
mesh_terms: D000595:Amino Acid Sequence; D000900:Anti-Bacterial Agents / Q000737:chemistry* / Q000494:pharmacology; D000998:Antiviral Agents / Q000737:chemistry* / Q000494:pharmacology; D015497:HIV-1 / Q000187:drug effects; D036341:Intercellular Signaling Peptides and Proteins; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D008969:Molecular Sequence Data; D015394:Molecular Structure; D010455:Peptides
chemical_list: D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D036341:Intercellular Signaling Peptides and Proteins; D010455:Peptides; C094260:siamycin I; C094261:siamycin II